Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |